[2]
Mozaffarian, D.; Benjamin, E.J.; Go, A.S.; Arnett, D.K.; Blaha, M.J.; Cushman, M.; Das, S.R.; de Ferranti, S.; Després, J.P.; Fullerton, H.J.; Howard, V.J.; Huffman, M.D.; Isasi, C.R.; Jiménez, M.C.; Judd, S.E.; Kissela, B.M.; Lichtman, J.H.; Lisabeth, L.D.; Liu, S.; Mackey, R.H.; Magid, D.J.; McGuire, D.K.; Mohler, E.R., III; Moy, C.S.; Muntner, P.; Mussolino, M.E.; Nasir, K.; Neumar, R.W.; Nichol, G.; Palaniappan, L.; Pandey, D.K.; Reeves, M.J.; Rodriguez, C.J.; Rosamond, W.; Sorlie, P.D.; Stein, J.; Towfighi, A.; Turan, T.N.; Virani, S.S.; Woo, D.; Yeh, R.W.; Turner, M.B. Executive summary: Heart disease and stroke statistics-2016 update: A report from the American Heart Association.
Circulation, 2016,
133(4), 447-454.
[
http://dx.doi.org/10.1161/CIR.0000000000000366] [PMID:
26811276]
[3]
Benjamin, E.J.; Blaha, M.J.; Chiuve, S.E.; Cushman, M.; Das, S.R.; Deo, R.; de Ferranti, S.D.; Floyd, J.; Fornage, M.; Gillespie, C.; Isasi, C.R.; Jiménez, M.C.; Jordan, L.C.; Judd, S.E.; Lackland, D.; Lichtman, J.H.; Lisabeth, L.; Liu, S.; Longenecker, C.T.; Mackey, R.H.; Matsushita, K.; Mozaffarian, D.; Mussolino, M.E.; Nasir, K.; Neumar, R.W.; Palaniappan, L.; Pandey, D.K.; Thiagarajan, R.R.; Reeves, M.J.; Ritchey, M.; Rodriguez, C.J.; Roth, G.A.; Rosamond, W.D.; Sasson, C.; Towfighi, A.; Tsao, C.W.; Turner, M.B.; Virani, S.S.; Voeks, J.H.; Willey, J.Z.; Wilkins, J.T.; Wu, J.H.Y.; Alger, H.M.; Wong, S.S.; Muntner, P. Heart disease and stroke statistics—2017 update: A report from the American Heart Association.
Circulation, 2017,
135(10), e146-e603.
[
http://dx.doi.org/10.1161/CIR.0000000000000485] [PMID:
28122885]
[4]
Cristea, C.; Florea, A.; Tertiș, M.; Săndulescu, R. Immunosensors In: Biosensors-Micro and Nanoscale Applications; Rinken, T., Ed.; IntechOpen: London, 2015.
[5]
Ellington, A.D.; Szostak, J.W. In vitro selection of RNA molecules that bind specific ligands. Nature, 1990, 346(6287), 818-822.
[6]
Stoltenburg, R.; Reinemann, C.; Strehlitz, B. SELEX-A (r)evolutionary method to generate high-affinity nucleic acid ligands. Biomol. Eng., 2007, 24(4), 381-403.
[7]
Bauer, M.; Strom, M.; Hammond, D.S.; Shigdar, S.J.M. Anything you can do, I can do better: Can Aptamers replace antibodies in clinical diagnostic applications? Molecules, 2019, 24(23), 4377.
[8]
Jayasena, S.D. Aptamers: An emerging class of molecules that rival antibodies in diagnostics. Clin. Chem., 1999, 45(9), 1628-1650.
[9]
Rapini, R.; Marrazza, G.J.B. Electrochemical aptasensors for contaminants detection in food and environment: Recent advances. Bioelectrochemistry, 2017, 118, 47-61.
[11]
Stanciu, L.A.; Wei, Q.; Barui, A.K.; Mohammad, N. Recent advances in aptamer-based biosensors for global health applications. Annu. Rev. Biomed. Eng., 2021, 23, 433-459.
[13]
Rhouati, A.; Marty, J-L.; Vasilescu, A.J.N. Metal nanomaterial-assisted aptasensors for emerging pollutants detection. In: Nanotechnology and Biosensors, Nikolelis D.P; Nikoleli, G.P., Ed.; Elsevier, 2018; pp. 193-231.
[14]
Barua, S.; Dutta, H.S.; Gogoi, S.; Devi, R.; Khan, R. Nanostructured MoS2-based advanced biosensors: A review. ACS Appl. Nano Mater., 2018, 1(1), 2-25.
[16]
Nguyen, T.; Hilton, J.P.; Lin, Q.J.M. Emerging applications of aptamers to micro- and nanoscale biosensing. Microfluid. Nanofluidics, 2009, 6(3), 347-362.
[20]
Potter, L.R.; Yoder, A.R.; Flora, D.R.; Antos, L. K Natriuretic peptides: Their structures, receptors, physiologic functions and therapeutic applications. Handb. Exp. Pharmacol., 2009, 191, 341-366.
[21]
Hamm, C.W.; Bassand, J.P.; Agewall, S.; Bax, J.; Boersma, E.; Bueno, H.; Caso, P.; Dudek, D.; Gielen, S.; Huber, K.; Ohman, M.; Petrie, M.C.; Sonntag, F.; Uva, M.S.; Storey, R.F.; Wijns, W.; Zahger, D.; Bax, J.J.; Auricchio, A.; Baumgartner, H.; Ceconi, C.; Dean, V.; Deaton, C.; Fagard, R.; Funck-Brentano, C.; Hasdai, D.; Hoes, A.; Knuuti, J.; Kolh, P.; McDonagh, T.; Moulin, C.; Poldermans, D.; Popescu, B.A.; Reiner, Z.; Sechtem, U.; Sirnes, P.A.; Torbicki, A.; Vahanian, A.; Windecker, S.; Windecker, S.; Achenbach, S.; Badimon, L.; Bertrand, M.; Botker, H.E.; Collet, J-P.; Crea, F.; Danchin, N.; Falk, E.; Goudevenos, J.; Gulba, D.; Hambrecht, R.; Herrmann, J.; Kastrati, A.; Kjeldsen, K.; Kristensen, S.D.; Lancellotti, P.; Mehilli, J.; Merkely, B.; Montalescot, G.; Neumann, F-J.; Neyses, L.; Perk, J.; Roffi, M.; Romeo, F.; Ruda, M.; Swahn, E.; Valgimigli, M.; Vrints, C.J.; Widimsky, P. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of Acute Coronary Syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC).
Eur. Heart J., 2011,
32(23), 2999-3054.
[
http://dx.doi.org/10.1093/eurheartj/ehr236] [PMID:
21873419]
[22]
Dickstein, K.; Cohen-Solal, A.; Filippatos, G. Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: Task force for diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Eur. Heart J., 2008, 29, 2388.
[23]
Federico, C. Natriuretic peptide system and cardiovascular disease. Heart Views, 2010, 11(1), 10-15.
[41]
Sassolas, A.; Blum, L.J. Leca‐Bouvier, B.D. Electrochemical aptasensors. Electroanalysis, 2009, 21(11), 1237-1250.
,
Adel Rhouati
Download PDF Flyer